Academic Research

Artificial intelligence in healthcare has long carried a promise: faster diagnoses, predictive risk scores, and precision interventions, all at scale. But recent years have exposed a caveat baked into that optimism: if the training data isn’t representative, the output can’t be trusted. The result is a clinical inequity.

Hidden injuries have always been one of the most insidious threats in military medicine. From early battlefield concussion to long-term neurological impairment, brain trauma often escapes early detection, particularly in soldiers exposed to repeated low-level blasts.

The announcement from the Icahn School of Medicine at Mount Sinai that its researchers have developed an AI-powered approach to determine the penetrance of rare genetic variants marks a strategic breakthrough, not just in genomics, but in how healthcare organizations operationalize genetic information. By using routine lab tests and machine learning to estimate the real-world disease risk associated with rare variants, Mount Sinai’s team is reframing what genomic data means in clinical care.

The expansion of virtual reality (VR) training in emergency medicine, as demonstrated by Chulalongkorn University’s nationwide rollout of its ER-VIPE platform, signals a larger shift in how global health systems are redefining preparedness, team performance, and workforce resiliency. The program, designed to improve real-time collaboration among emergency clinicians through gamified, VR-based simulations, offers more than an instructional upgrade. It highlights an emerging operational strategy: using immersive, low-risk environments to hardwire team-based competencies at scale.

The debut of MARQO, a next-generation image analysis tool developed by researchers at the Icahn School of Medicine at Mount Sinai, marks more than a technical advancement in oncology research. It signals a strategic inflection point in the evolution of diagnostic pathology, one that challenges longstanding assumptions about speed, scale, and the role of human interpretation in cancer care.

The promise of artificial intelligence in mental health care is rapidly transitioning from experimental to operational. For breast cancer patients in particular, AI-based interventions could radically reshape how psychological distress is detected, triaged, and managed across settings. But the core question remains unresolved: Will these systems meaningfully extend care, or create a new layer of digital inequity?

Efforts to fully automate insulin delivery for type 1 diabetes are entering a critical inflection point. For nearly a decade, the artificial pancreas has promised to transform care for millions of people managing the condition. But even with notable advancements in hybrid closed-loop systems, a fundamental barrier remains: user burden.

Emergency department (ED) overcrowding is not a new problem, but artificial intelligence may finally be offering new tools to address it. A large-scale, multi-hospital study from the Mount Sinai Health System shows that AI can accurately predict which ED patients will require hospital admission, hours earlier than traditional workflows allow.